Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system

Journal of Heart and Lung Transplantation

Volumn 31, Issue 6, 2012, Pages 601-610

  Yang, Jonathan A ^a   Kato, Tomoko S ^a   Shulman, Brittney P ^a   Takayama, Hiroo ^a   Farr, Maryjane ^a   Jorde, Ulrich P ^a   Mancini, Donna M ^a   Naka, Yoshifumi ^a   Schulze, P Christian ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

cardiomyopathy; liver dysfunction; risk assessment; transplantation; ventricular assist device

Indexed keywords

BILIRUBIN; CREATININE;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIOMYOPATHY; CHOLESTASIS; CREATININE BLOOD LEVEL; FEMALE; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MELD EXCLUDING INR SCORE; MODEL OF END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOMES RESEARCH; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; AGED; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84862780641     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.02.027     Document Type: Article

References (13)

1. C.C. Giallourakis, P.M. Rosenberg, L.S. Friedman The liver in heart failure Clin Liver Dis 6 2002 viii viix
2. U.D. Bayraktar, S. Seren, Y. Bayraktar Hepatic venous outflow obstruction: three similar syndromes World J Gastroenterol 13 2007 1912 1927
3. G.T. Lau, H.C. Tan, L. Kritharides Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation Am J Cardiol 90 2002 1405 1409
4. R.P. Myers, R. Cerini, R. Sayegh Cardiac hepatopathy: clinical, hemodynamic, and histologic characteristics and correlations Hepatology 37 2003 393 400
5. W. Dichtl, W. Vogel, K.M. Dunst Cardiac hepatopathy before and after heart transplantation Transpl Int 18 2005 697 702
6. M. Malinchoc, P.S. Kamath, F.D. Gordon, C.J. Peine, J. Rank, P.C. ter Borg A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
7. R.H. Kamath Wiesner, M. Malinchoc A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
8. United Network of Organ Sharing MELD/PELD calculator documentation http://www.unos.org/SharedContentDocuments/MELD-PELD-Calculator-Documentation. pdf 2009 Accessed Oct 21, 2011
9. R.B. Freeman, R.H. Wiesner, E. Edwards Results of the first year of the new liver allocation plan Liver Transpl 10 2004 7 15
10. S.H. Teh, D.M. Nagorney, S.R. Stevens Risk factors for mortality after surgery in patients with cirrhosis Gastroenterology 132 2007 1261 1269
11. E.A. Rose, A.C. Gelijns, A.J. Moskowitz Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
12. J.C. Matthews, F.D. Pagani, J.W. Haft Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality Circulation 121 2010 214 220
13. D.M. Heuman, A.A. Mihas, A. Habib MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy Liver Transpl 13 2007 30 37